nderstanding the role of pyrimidine compound in breast cancer
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2023/11/059474
- Lead Sponsor
- PRAMOD KUMAR AVTI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
In this study only female breast cancer patients will be included.
Breast cancer patients age18- 60 years.
The diagnosis of the patient through mammographic techniques.
Patients at all stages of the disease will be included.
Surgery or mastectomy patients will be included.
With or without treatment patients will be included in this study.
Exclusion Criteria
Age < 18 or >60.
Patients with a psychiatric disorder.
Patients with multiple malignancies.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Post surgical breast tumor tissue/blood will be collected for hormonal receptor expression. <br/ ><br>Timepoint: 2. The collected tissue samples analysis will be performed within 4-6 weeks
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI